1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Results 61-80 of 155 (Search time: 0.015 seconds).

Issue DateTitleAuthor(s)
61Nov-2022Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.Spencer, Andrew; Samoilova, Olga; Chng, Wee-Joo ; Labotka, Richard; Li, Cong; Wu, Kwang-Wei; Saxena, Nakul; Yan, Xu; Lee, Jae Hoon; Beksac, Meral
621-Jan-2017Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyMoreau, P; Joshua, D; Chng, W-J ; Palumbo, A; Goldschmidt, H; Hajek, R; Facon, T; Ludwig, H; Pour, L; Niesvizky, R; Oriol, A; Rosinol, L; Suvorov, A; Gaidano, G; Pika, T; Weisel, K; Goranova-Marinova, V; Gillenwater, HH; Mohamed, N; Aggarwal, S; Feng, S; Dimopoulos, MA
32014Implications of heterogeneity in multiple myelomaDe Mel S.; Lim S.H.; Tung M.L.; Chng W.-J. 
4Feb-2014IMWG consensus on risk stratification in multiple myelomaChng, W.J. ; Dispenzieri, A.; Chim, C.-S.; Fonseca, R.; Goldschmidt, H.; Lentzsch, S.; Munshi, N.; Palumbo, A.; Miguel, J.S.; Sonneveld, P.; Cavo, M.; Usmani, S.; Durie, B.G.; Avet-Loiseau, H.
52010Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell modelYustein, J.T.; Liu, Y.-C.; Vuica-Ross, M.; Eberhart, C.G.; Dang, C.V.; Gao, P.; Le, A.; Jie, C.; Chng, W.J. ; Bergsagel, P.L.
62017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
71-Dec-2020Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 TrialDimopoulos, Meletios A; Spicka, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo ; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria-Victoria; Morgan, Gareth; Vorog, Alexander; Labotka, Richard; Wang, Bingxia; Palumbo, Antonio; Lonial, Sagar
81-Oct-2021Janus Kinase Signaling: Oncogenic Criminal of Lymphoid CancersLi, Boheng; Wan, Qin; Li, Zhubo; Chng, Wee-Joo 
92018LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)Hee, Y.T; Yan, J ; Nizetic, D; Chng, W.-J 
101-Mar-2017LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AMLZhou, Jianbiao ; Chan, Zit-Liang; Bi, Chonglei; Lu, Xiao; Chong, Phyllis SY ; Chooi, Jing-Yuan ; Cheong, Lip-Lee; Liu, Shaw-Cheng; Ching, Ying Qing ; Zhou, Yafeng; Osato, Motomi; Tan, Tuan Zea ; Ng, Chin Hin ; Ng, Siok-Bian ; Wang, Shi ; Zeng, Qi ; Chng, Wee-Joo 
111-Dec-2021Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or strokeKoo, CY ; Zheng, H ; Tan, LL ; Foo, LL; Seet, R ; Chong, JH ; Hausenloy, DJ ; Chng, WJ ; Richards, AM ; Lee, CH ; Chan, MY 
122-Dec-2019Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochipKhoo, Bee Luan; Shang, Menglin; Ng, Chin Hin; Lim, Chwee Teck ; Chng, Wee Joo ; Han, Jongyoon
13Nov-2013Management of multiple myeloma in asia: Resource-stratified guidelinesTan, D.; Chng, W.J. ; Chou, T.; Nawarawong, W.; Hwang, S.-Y.; Chim, C.S.; Chen, W.; Durie, B.G.M.; Lee, J.H.
14Apr-2012Management of treatment-emergent peripheral neuropathy in multiple myelomaRichardson, P.G.; Delforge, M.; Beksac, M.; Wen, P.; Jongen, J.L.; Sezer, O.; Terpos, E.; Munshi, N.; Palumbo, A.; Rajkumar, S.V.; Harousseau, J.L.; Moreau, P.; Avet-Loiseau, H.; Lee, J.H.; Cavo, M.; Merlini, G.; Voorhees, P.; Chng, W.J. ; Mazumder, A.; Usmani, S.; Einsele, H.; Comenzo, R.; Orlowski, R.; Vesole, D.; Lahuerta, J.J.; Niesvizky, R.; Siegel, D.; Mateos, M.-V.; Dimopoulos, M.; Lonial, S.; Jagannath, S.; Bladé, J.; Miguel, J.S.; Morgan, G.; Anderson, K.C.; Durie, B.G.M.; Sonneveld, P.
151-Feb-2021Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportMurray, David L; Puig, Noemi; Kristinsson, Sigurdur; Usmani, Saad Z; Dispenzieri, Angela; Bianchi, Giada; Kumar, Shaji; Chng, Wee Joo ; Hajek, Roman; Paiva, Bruno; Waage, Anders; Rajkumar, S Vincent; Durie, Brian
165-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
171-Apr-2022Metabolic Vulnerabilities in Multiple MyelomaLim, Julia SL ; Chong, Phyllis SY ; Chng, Wee-Joo 
1819-Aug-2010"Micro"-managing the MiRNome in SzSChng, W.J. 
191-Oct-2020Microenvironmental Hypoxia Induces Dynamic Changes in Lung Cancer Synthesis and Secretion of Extracellular VesiclesTse, Shun Wilford; Tan, Chee Fan; Park, Jung Eun; Gnanasekaran, JebaMercy; Gupta, Nikhil; Low, Jee Keem; Yeoh, Kheng Wei; Chng, Wee Joo ; Tay, Chor Yong; McCarthy, Neil E; Lim, Sai Kiang; Sze, Siu Kwan
202-Feb-2006MicroRNA in chronic lymphocytic leukemia [2]Chng, W.J.